SCHEMBL19424767

SCHEMBL19424767

CC1(C)CCC(CN2CCN(c3ccc(C(=O)NS(=O)(=O)c4ccc(OCCC5CCOCC5)c(NO)c4)c(Oc4cccc5[nH]ccc45)c3)CC2)=C(c2ccc(Cl)cc2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1956188 0.93 BCL2 (0.77) —
SCHEMBL19424978 0.89 BCL2 (0.74) —
SCHEMBL1957124 0.89 BCL2 (0.83) —
SCHEMBL19424757 0.88 BCL2 (0.77) —
SCHEMBL19419655 0.88 BCL2 (0.76) —
SCHEMBL1957592 0.88 BCL2 (0.86) —
SCHEMBL1958491 0.87 BCL2 (0.83) —
SCHEMBL1955281 0.87 BCL2 (0.78) —
SCHEMBL1956189 0.86 BCL2 (0.83) —
SCHEMBL1956395 0.85 BCL2 (0.76) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10195213-B2 Chemical entities that kill senescent cells for use in treating age-related disease UNITY BIOTECHNOLOGY, INC. (US) 2019-02-05 — — US disclosed
US-20170281649-A1 COMPOUNDS AND THERAPEUTIC USES UNITY BIOTECHNOLOGY, INC. 2017-10-05 — — US disclosed
Send feedback